Yoke between COVID-19 infection and cardiovascular diseases: Evidence briefing from Indian studies

Globally, cardiovascular diseases (CVDs) are of major concern. The current pandemic situation of Coronavirus Disease 19 (COVID-19) infection has further hiked the burden of cardiovascular problems. Since India has a large number of cases with cardiovascular problems the interlink between the COVID-19 infection and CVDs has greatly challenged the field of medicine. The interaction between the drugs used in the management of COVID infection and cardiovascular problems is another major area of concern. With the variant nature of the Coronavirus, cases have surged leading to increased mortality and one of the major causes for mortality is cardiovascular complications. This article aims to reflect on the effect of cardiovascular morbidity on COVID-19 infection and the cardiovascular outcome of COVID-19 positive patients in India. The relevant articles for the review were searched using the three databases: CINHAL, Scopus, and PubMed and the search was limited to the studies conducted from January 2020 till May 2021. The review highlighted that Diabetes and Hypertension were the most common comorbidity and were the major contributing factors for the mortality among patients diagnosed with COVID-19 in India.